Sublocade Therapy for Opioid Use Disorder

What it is

Sublocade is an FDA-approved, once-monthly extended-release buprenorphine injection for moderate to severe opioid use disorder.

Official info: https://www.sublocade.com

Why it’s offered

Sublocade helps stabilize patients by reducing cravings and withdrawal symptoms, supporting long-term recovery and improving treatment adherence.

How it works

Sublocade releases buprenorphine steadily over 30 days. Buprenorphine is a partial opioid agonist that activates receptors enough to reduce cravings but not enough to produce a full opioid effect.

What treatment includes

Comprehensive evaluation for opioid use disorder • Transition from daily buprenorphine when needed • Monthly injections administered by medical staff • Regular monitoring and behavioral health support Important notes Sublocade works best when combined with counseling and structured recovery programs. It is not a standalone cure.